CN104434845B — 一种包含利奥西呱的固体药物制剂
Assigned to Guangdong HEC Pharmaceutical Co Ltd · Expires 2017-12-05 · 8y expired
What this patent protects
本发明提供了一种包含利奥西呱的固体药物制剂,按照重量份数计算,包含治疗有效量的利奥西呱2.5份、水溶性聚合物10~40份、稀释剂40~70份、崩解剂5~10份、润滑剂1~10份。本发明提供的固体药物制剂采用水溶性聚合物材料作为药物载体,生物相容性好,含量均匀度高,毒副作用低;而且水溶性聚合物材料有利于促进难溶性药物的溶出,药物溶出快。本发明制备工艺简单,成本低,适于工业化生产。
USPTO Abstract
本发明提供了一种包含利奥西呱的固体药物制剂,按照重量份数计算,包含治疗有效量的利奥西呱2.5份、水溶性聚合物10~40份、稀释剂40~70份、崩解剂5~10份、润滑剂1~10份。本发明提供的固体药物制剂采用水溶性聚合物材料作为药物载体,生物相容性好,含量均匀度高,毒副作用低;而且水溶性聚合物材料有利于促进难溶性药物的溶出,药物溶出快。本发明制备工艺简单,成本低,适于工业化生产。
Drugs covered by this patent
- Adempas (RIOCIGUAT) · Bayer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.